Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Benjamin Edwards Inc. Bolsters Stake in Amgen

Guavy AI Editorial Team
Instruments
AMGN
Share

Benjamin Edwards Inc., an institutional investor, increased its stake in Amgen Inc. (NASDAQ:AMGN) by purchasing an additional 6,790 shares during the second quarter.

This move brought their total holdings to 74,607 shares, valued at $27,026,000 as of the end of the most recent quarter.

Amgen's latest reported quarter exceeded analyst expectations for both earnings and revenue, with revenue increasing year over year. The company has set its FY 2026 guidance at 22.300-23.500 EPS.

More on Stocks

Stocks 8m ago

Nissay Asset Management Cuts Salesforce Stake

Stocks 8m ago

Salesforce Crushes Earnings Guidance, Dismisses AI-Fueled Software Collapse Fears

Stocks 8m ago

Swedish Life Insurance Firm Bets Big on Salesforce

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy